Testicular Cancer Treatment Options
Navigating a diagnosis of testicular cancer can be daunting, but understanding the available testicular cancer treatment options is a crucial step toward recovery. This article provides an overview of the approaches used to treat this disease, from initial diagnosis to managing post-treatment effects.
Key Takeaways
- Testicular cancer treatment is individualized based on the tumor type — seminoma or non-seminoma — the stage at diagnosis, and the patient’s overall health.
- Surgery to remove the affected testicle, called radical inguinal orchiectomy, is almost always the first step and both confirms the diagnosis and removes the primary tumor.
- Depending on the type and stage, additional treatment may include retroperitoneal lymph node dissection, radiation therapy (mainly for seminoma), or chemotherapy such as the BEP regimen.
- For many patients with early-stage disease, active surveillance after orchiectomy is a standard option, since any relapse that occurs is usually still highly treatable.
- Because chemotherapy, radiation, and lymph node surgery can affect fertility, discussing sperm banking before treatment begins is an important part of care.
Understanding Your Testicular Cancer Treatment Plan
A personalized treatment plan for testicular cancer begins with a thorough understanding of the disease’s characteristics. The approach taken depends on several factors, helping the care team choose the most effective strategy for each patient.
Initial Diagnosis & Staging
Determining the right treatment starts with an accurate diagnosis and staging. This typically involves a physical examination, blood tests for tumor markers — alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and lactate dehydrogenase (LDH) — and imaging, including an ultrasound of the testicle and a CT scan of the abdomen and chest to check for spread. These tumor markers are measured before the affected testicle is removed and are checked again afterward, since a level that stays elevated can be one of the earliest signs that cancer remains. Testicular cancer is broadly divided into two types, seminoma and non-seminoma, which follow somewhat different treatment paths; how the disease is staged in each case is covered in more detail on our testicular cancer staging page.
Factors Guiding Treatment Choices
Several factors influence which testicular cancer treatment options are most appropriate: the tumor type, the stage of disease, tumor marker levels after orchiectomy, and the patient’s overall health and preferences about potential side effects. For stage I seminoma, standard options after orchiectomy include watchful surveillance, adjuvant radiation aimed at nearby lymph nodes, or carboplatin chemotherapy given as a one-time dose. For stage I non-seminoma, surveillance, retroperitoneal lymph node dissection, or one to two cycles of chemotherapy are all standard choices. Each approach carries a different balance of relapse risk and treatment burden, and no single strategy has been shown to improve long-term survival over the others, so the decision is made together with the care team.
Surgical Interventions for Testicular Cancer
Surgery is a cornerstone of testicular cancer treatment, often serving as both a diagnostic tool and the primary method of removing the cancerous tissue. The type of surgery performed depends on the stage and type of the cancer.
Radical Inguinal Orchiectomy
The first and most common procedure for testicular cancer is radical inguinal orchiectomy, in which the entire affected testicle and spermatic cord are removed through an incision in the groin, with the spermatic cord tied off near the abdomen. A biopsy taken directly through the scrotum is avoided because of the risk of spreading cancer cells locally. This procedure both confirms the diagnosis, through pathological examination of the removed tissue, and removes the primary tumor, making it an essential first step in nearly every case. Removing one testicle does not usually affect fertility or hormone production as long as the remaining testicle is healthy, and patients who wish to can be offered a prosthetic testicle for cosmetic reasons.
Retroperitoneal Lymph Node Dissection (RPLND)
For certain types and stages of testicular cancer, particularly non-seminoma, doctors may recommend a more extensive operation called retroperitoneal lymph node dissection, or RPLND. This procedure removes lymph nodes located in the back of the abdomen (the retroperitoneum), a common site for testicular cancer to spread. RPLND can be used to stage the disease more accurately when imaging is inconclusive, or as treatment to remove lymph nodes already known to contain cancer. It is a complex operation, and outcomes tend to be best at centers experienced in the technique. According to the NCI, men found to have cancer in the lymph nodes at RPLND are usually given one or two cycles of chemotherapy afterward, which lowers the chance of relapse to about 1%.
Chemotherapy and Radiation Therapy Explained
Beyond surgery, systemic treatment with chemotherapy and localized treatment with radiation therapy play important roles in eliminating remaining cancer cells and reducing the chance of recurrence, especially for more advanced disease.
Common Chemotherapy Regimens
Chemotherapy drugs circulate in the blood and reach cancer cells wherever they may have spread. This treatment is commonly used after surgery to eliminate any remaining microscopic disease (adjuvant therapy), or as the primary treatment once the cancer has already reached lymph nodes or other organs. The standard regimen for testicular cancer is BEP — bleomycin, etoposide, and cisplatin — typically given over three or four 21-day cycles depending on the risk group. For patients who cannot receive bleomycin, alternatives include EP (etoposide and cisplatin) or, for higher-risk disease, VIP (etoposide, ifosfamide, and cisplatin). These regimens are given in cycles over several weeks, allowing the body to recover between doses.
Targeted Radiation Therapy Uses
Radiation therapy uses high-energy x-rays to destroy cancer cells, and for testicular cancer it is used almost exclusively for seminoma, since this subtype tends to respond well to radiation while non-seminoma generally does not. When used after orchiectomy for early-stage seminoma, radiation is aimed at the lymph nodes in the abdomen, and current regimens use lower doses than were used in the past because studies have shown that a reduced dose works just as well while causing fewer side effects. At the same time, because radiation for early-stage seminoma has been linked to a higher long-term risk of second cancers, many patients and doctors now prefer surveillance or a single dose of carboplatin chemotherapy instead, reserving radiation for situations where those options are not suitable.
New and Emerging Testicular Cancer Treatments
For testicular cancer that returns after standard treatment or does not respond fully to it, high-dose chemotherapy paired with a stem cell transplant is an established option. In this approach, a patient’s own blood-forming stem cells are collected and stored before very high doses of chemotherapy are given; the stored cells are then returned to help the bone marrow recover, which lets doctors use more intensive drug doses than standard chemotherapy would allow. Clinical trials continue to explore other approaches for patients whose cancer does not respond to standard options; the latest findings from this research are covered in more detail on our dedicated testicular cancer research page.
Managing Side Effects of Testicular Cancer Therapy
Undergoing treatment for testicular cancer can bring a mix of physical and emotional side effects, and understanding which treatment tends to cause which effect is part of preparing for care. Surgery typically causes short-term incision pain and a small risk of infection, and some men have concerns about body image after losing a testicle, though a prosthetic implant is an option. Chemotherapy and radiation can each cause more systemic effects, and one of the most significant is that fertility can drop temporarily or, less often, permanently, making a conversation about sperm banking ahead of treatment worthwhile for men who may want children in the future. Practical strategies for coping with these effects during and after therapy are discussed in depth on our page devoted to managing testicular cancer treatment side effects.
Frequently Asked Questions
How effective are testicular cancer treatments?
Testicular cancer is considered one of the most curable solid tumors when it is treated according to standard protocols, even in cases where the disease has spread beyond the testicle at diagnosis. The exact outlook depends on the tumor type, the stage, and how tumor markers respond to treatment, and detailed cure and survival statistics for each of these groups are presented on our testicular cancer survival rate page. Following the recommended treatment and follow-up schedule gives patients the best chance of a good outcome.
What are the long-term impacts on fertility after treatment?
Testicular cancer treatment — particularly chemotherapy, radiation therapy, and RPLND — can reduce fertility, sometimes temporarily and sometimes permanently, though removing one testicle (orchiectomy) alone usually leaves the remaining testicle able to produce sperm and hormones normally. Because of this risk, many patients choose to bank sperm before starting chemotherapy or radiation, and discussing fertility preservation with the care team before treatment begins is recommended. Hormone levels and sperm counts can be checked afterward to help assess fertility status.
How often is follow-up care needed after treatment?
After completing treatment, regular follow-up is essential to watch for recurrence and manage any lasting effects of treatment. The schedule depends on the initial stage and type of cancer, but it typically includes physical exams, blood tests for tumor markers, and periodic CT scans, spaced closer together in the first year or two and then gradually further apart. Testicular cancer survivors face a higher chance of a second cancer developing in the remaining testicle, so doctors advise regular self-checks and prompt reporting of any changes.
Sources
